Search
for

    Sort by

    Research 91–120 of 1000+

    1. Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 3 citations
    2. Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells PLoS Pathogens · 2022 · 1 citations
    3. NOVEL CORONAVIRUS (SARS-COV-2): MOLECULAR BIOLOGY, PATHOGENESIS, PATHOBIOLOGY AND ADVANCES IN TREATMENT OF COVID-19 PATIENTS– AN UPDATE Journal of Experimental Biology and Agricultural Sciences · 2020 · 1 citations
    4. A narrative review of SARS-CoV-2 variants and long COVID Journal of Thoracic Disease · 2026
    5. Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management Diseases · 2025
    6. Hair loss after SARS-CoV2 Infection Journal of Education, Health and Sport · 2022
    7. Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients Briefings in Bioinformatics · 2020 · 82 citations
    8. Medical education and care in dermatology during the SARS‐CoV2 pandemia: challenges and chances Journal of the European Academy of Dermatology and Venereology · 2020 · 44 citations
    9. Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2 FEBS Open Bio · 2021 · 29 citations
    10. Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 18 citations
    11. Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA Viruses · 2023 · 9 citations
    12. Virtual Screening of Potential Inhibitors for SARS-CoV-2 Main Protease 2020 · 8 citations
    13. Genetic Variants and Protective Immunity against SARS-CoV-2 Genes · 2022 · 5 citations
    14. TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target Medeniyet Medical Journal · 2025 · 4 citations
    15. Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period Journal of Infection · 2022 · 3 citations
    16. Natural Products as A Promising Therapy for SARS COV-2; An Overview Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512) · 2021 · 3 citations
    17. Genetic and hormonal influence on SARS-CoV-2-infection susceptibility Annals of Oncology · 2020 · 2 citations
    18. The clinical course and outcomes of SARS-CoV-2 virus infection in children: a 24-week follow-up study in Sulaimaniyah, Iraq BMC Pediatrics · 2023 · 1 citations
    19. Identifying long-term effects of SARS-CoV-2 and their association with social determinants of health in a cohort of over one million COVID-19 survivors BMC Public Health · 2022 · 1 citations
    20. Computational Screening of Repurposed Drugs Targeting Sars-Cov-2 Main Protease By Molecular Docking Sudan Journal of Medical Sciences · 2022 · 1 citations
    21. Research progress of post-acute sequelae after SARS-CoV-2 infection Cell death and disease · 2024
    22. Impact of the new corona virus (SARS-CoV-2) pandemic on climateric women’s health: websurvey Maturitas · 2023
    23. MANIFESTAÇÕES CUTÂNEAS CORROBORADAS À INFECÇÃO POR SARS-COV-2 Amplla Editora eBooks · 2022
    24. The role of testosterone in SARS-CoV-2 infection Research Outreach · 2021
    25. Identifying Long-Term Effects of SARS-CoV-2 and Their Association with Social Determinants of Health in a Cohort of Over One Million COVID-19 Survivors Research Square (Research Square) · 2021
    26. Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2 2021
    27. NATURAL ANTIVIRALS FOR THE MANAGEMENT OF SARS-COVID-19: A REVIEW International Journal of Research in Ayurveda and Pharmacy · 2021
    28. Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods Pharmaceuticals · 2021 · 42 citations
    29. Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship BioMed · 2023 · 15 citations
    30. Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil International Journal of Environmental Research and Public Health · 2022 · 13 citations